Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage.

McElroy JP, Carmella SG, Heskin AK, Tang MK, Murphy SE, Reisinger SA, Jensen JA, Hatsukami DK, Hecht SS, Shields PG.

PLoS One. 2019 Jun 28;14(6):e0218386. doi: 10.1371/journal.pone.0218386. eCollection 2019.

2.

Active and secondhand smoke exposure throughout life and DNA methylation in breast tumors.

Callahan CL, Bonner MR, Nie J, Wang Y, Tao MH, Shields PG, Marian C, Eng KH, Trevisan M, Freudenheim JL.

Cancer Causes Control. 2019 Jan;30(1):53-62. doi: 10.1007/s10552-018-1102-4. Epub 2019 Jan 7.

PMID:
30617699
3.

Electronic versus Combustible Cigarette Effects on Inflammasome Component Release into Human Lung.

Tsai M, Song MA, McAndrew C, Brasky TM, Freudenheim JL, Mathé E, McElroy J, Reisinger SA, Shields PG, Wewers MD.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):922-925. doi: 10.1164/rccm.201808-1467LE. No abstract available.

PMID:
30608866
4.

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database.

Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG.

Radiat Oncol. 2018 Oct 5;13(1):196. doi: 10.1186/s13014-018-1142-7.

5.

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer.

Owen DH, Wei L, Bertino EM, Edd T, Villalona-Calero MA, He K, Shields PG, Carbone DP, Otterson GA.

Clin Lung Cancer. 2018 Nov;19(6):e893-e900. doi: 10.1016/j.cllc.2018.08.008. Epub 2018 Aug 22.

6.

Electronic Cigarettes and the Lung Proteome.

Shields PG, Song MA, Freudenheim JL, Brasky TM, Mathe E, McElroy JP, Hummon AB, Wewers MD.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1350-1351. doi: 10.1164/rccm.201806-1151LE. No abstract available.

PMID:
30153045
7.

Stromal PTEN determines mammary epithelial response to radiotherapy.

Sizemore GM, Balakrishnan S, Thies KA, Hammer AM, Sizemore ST, Trimboli AJ, Cuitiño MC, Steck SA, Tozbikian G, Kladney RD, Shinde N, Das M, Park D, Majumder S, Krishnan S, Yu L, Fernandez SA, Chakravarti A, Shields PG, White JR, Yee LD, Rosol TJ, Ludwig T, Park M, Leone G, Ostrowski MC.

Nat Commun. 2018 Jul 17;9(1):2783. doi: 10.1038/s41467-018-05266-6.

8.

Characteristics of the Tobacco User Adult Cohort in Urban and Rural Ohio.

Brasky TM, Hinton A, Doogan NJ, Cooper SE, Nagaraja HN, Xi W, Shields PG, Wewers ME.

Tob Regul Sci. 2018 Jan;4(1):614-630. doi: 10.18001/TRS.4.1.8. Epub 2018 Jan 1.

9.

Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.

Hampel H, Pearlman R, Beightol M, Zhao W, Jones D, Frankel WL, Goodfellow PJ, Yilmaz A, Miller K, Bacher J, Jacobson A, Paskett E, Shields PG, Goldberg RM, de la Chapelle A, Shirts BH, Pritchard CC; Ohio Colorectal Cancer Prevention Initiative Study Group.

JAMA Oncol. 2018 Jun 1;4(6):806-813. doi: 10.1001/jamaoncol.2018.0104.

10.

Strong preference for mint snus flavor among research participants.

Schneller LM, Lindgren BR, Shields PG, Hatsukami DK, O'Connor RJ.

Addict Behav Rep. 2017 Jul 31;6:51-55. doi: 10.1016/j.abrep.2017.07.004. eCollection 2017 Dec.

11.

Landscape of genome-wide age-related DNA methylation in breast tissue.

Song MA, Brasky TM, Weng DY, McElroy JP, Marian C, Higgins MJ, Ambrosone C, Spear SL, Llanos AA, Kallakury BVS, Freudenheim JL, Shields PG.

Oncotarget. 2017 Nov 29;8(70):114648-114662. doi: 10.18632/oncotarget.22754. eCollection 2017 Dec 29.

12.

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer.

Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG.

J Thorac Oncol. 2018 Mar;13(3):426-435. doi: 10.1016/j.jtho.2017.11.135. Epub 2018 Jan 8.

13.

Sleep and Breast Cancer in the Western New York Exposures and Breast Cancer (WEB) Study.

Vaughn CB, Freudenheim JL, Nie J, Sucheston-Campbell L, Wactawski-Wende J, Marian C, Shields PG, Kallakury BV, Trevisan M, Ochs-Balcom HM.

J Clin Sleep Med. 2018 Jan 15;14(1):81-86. doi: 10.5664/jcsm.6886.

14.

Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors.

Callahan CL, Bonner MR, Nie J, Han D, Wang Y, Tao MH, Shields PG, Marian C, Eng KH, Trevisan M, Beyea J, Freudenheim JL.

Environ Res. 2018 Feb;161:418-424. doi: 10.1016/j.envres.2017.11.040.

15.

Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.

Berman ML, Bickel WK, Harris AC, LeSage MG, O'Connor RJ, Stepanov I, Shields PG, Hatsukami DK.

Nicotine Tob Res. 2018 Sep 25;20(11):1292-1300. doi: 10.1093/ntr/ntx228.

PMID:
29059363
16.

Evaluating the utility of subjective effects measures for predicting product sampling, enrollment, and retention in a clinical trial of a smokeless tobacco product.

O'Connor RJ, Lindgren BR, Schneller LM, Shields PG, Hatsukami DK.

Addict Behav. 2018 Jan;76:95-99. doi: 10.1016/j.addbeh.2017.07.025. Epub 2017 Jul 14.

PMID:
28772248
17.

Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.

Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, Margolis KL, Qi L, Reding KW, Shields PG, Simon MS, Wactawski-Wende J, Wang A, Womack C, Manson JE.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1345-1348. doi: 10.1158/1055-9965.EPI-17-0096.

18.

A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.

Shields PG, Berman M, Brasky TM, Freudenheim JL, Mathe E, McElroy JP, Song MA, Wewers MD.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1175-1191. doi: 10.1158/1055-9965.EPI-17-0358. Epub 2017 Jun 22. Review.

19.

Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Song MA, Benowitz NL, Berman M, Brasky TM, Cummings KM, Hatsukami DK, Marian C, O'Connor R, Rees VW, Woroszylo C, Shields PG.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx075. Review.

20.

Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.

Haraldsdottir S, Rafnar T, Frankel WL, Einarsdottir S, Sigurdsson A, Hampel H, Snaebjornsson P, Masson G, Weng D, Arngrimsson R, Kehr B, Yilmaz A, Haraldsson S, Sulem P, Stefansson T, Shields PG, Sigurdsson F, Bekaii-Saab T, Moller PH, Steinarsdottir M, Alexiusdottir K, Hitchins M, Pritchard CC, de la Chapelle A, Jonasson JG, Goldberg RM, Stefansson K.

Nat Commun. 2017 May 3;8:14755. doi: 10.1038/ncomms14755.

21.

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, Goldberg RM, Paskett E, Shields PG, Freudenheim JL, Stanich PP, Lattimer I, Arnold M, Liyanarachchi S, Kalady M, Heald B, Greenwood C, Paquette I, Prues M, Draper DJ, Lindeman C, Kuebler JP, Reynolds K, Brell JM, Shaper AA, Mahesh S, Buie N, Weeman K, Shine K, Haut M, Edwards J, Bastola S, Wickham K, Khanduja KS, Zacks R, Pritchard CC, Shirts BH, Jacobson A, Allen B, de la Chapelle A, Hampel H; Ohio Colorectal Cancer Prevention Initiative Study Group.

JAMA Oncol. 2017 Apr 1;3(4):464-471. doi: 10.1001/jamaoncol.2016.5194.

22.

Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling.

Taslim C, Weng DY, Brasky TM, Dumitrescu RG, Huang K, Kallakury BV, Krishnan S, Llanos AA, Marian C, McElroy J, Schneider SS, Spear SL, Troester MA, Freudenheim JL, Geyer S, Shields PG.

Oncotarget. 2016 Dec 27;7(52):86457-86468. doi: 10.18632/oncotarget.13241.

23.

Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial.

Hatsukami DK, Luo X, Dick L, Kangkum M, Allen SS, Murphy SE, Hecht SS, Shields PG, al'Absi M.

Addiction. 2017 Jan;112(1):156-167. doi: 10.1111/add.13603. Epub 2016 Nov 2.

24.

Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S, Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J.

J Natl Compr Canc Netw. 2016 Nov;14(11):1430-1468.

PMID:
27799513
25.

Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies.

Shukuya T, Mori K, Amann JM, Bertino EM, Otterson GA, Shields PG, Morita S, Carbone DP.

J Thorac Oncol. 2016 Nov;11(11):1927-1939. doi: 10.1016/j.jtho.2016.07.017. Epub 2016 Aug 3.

26.

Menthol Smokers: Metabolomic Profiling and Smoking Behavior.

Hsu PC, Lan RS, Brasky TM, Marian C, Cheema AK, Ressom HW, Loffredo CA, Pickworth WB, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):51-60. doi: 10.1158/1055-9965.EPI-16-0124. Epub 2016 Sep 14.

27.

Metabolomic profiles of current cigarette smokers.

Hsu PC, Lan RS, Brasky TM, Marian C, Cheema AK, Ressom HW, Loffredo CA, Pickworth WB, Shields PG.

Mol Carcinog. 2017 Feb;56(2):594-606. doi: 10.1002/mc.22519. Epub 2016 Aug 22.

28.

Single-Nucleotide Polymorphisms and Markers of Oxidative Stress in Healthy Women.

Minlikeeva AN, Browne RW, Ochs-Balcom HM, Marian C, Shields PG, Trevisan M, Krishnan S, Modali R, Seddon M, Lehman T, Freudenheim JL.

PLoS One. 2016 Jun 7;11(6):e0156450. doi: 10.1371/journal.pone.0156450. eCollection 2016.

29.

DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.

Callahan CL, Wang Y, Marian C, Weng DY, Eng KH, Tao MH, Ambrosone CB, Nie J, Trevisan M, Smiraglia D, Edge SB, Shields PG, Freudenheim JL.

Epigenetics. 2016 Sep;11(9):643-652. doi: 10.1080/15592294.2016.1192735. Epub 2016 May 31.

30.

Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study.

Tao MH, Dai Q, Millen AE, Nie J, Edge SB, Trevisan M, Shields PG, Freudenheim JL.

Am J Cancer Res. 2015 Dec 15;6(1):105-13. eCollection 2016.

31.

Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from heathy women.

Song MA, Brasky TM, Marian C, Weng DY, Taslim C, Llanos AA, Dumitrescu RG, Liu Z, Mason JB, Spear SL, Kallakury BV, Freudenheim JL, Shields PG.

Carcinogenesis. 2016 Mar 9. pii: bgw030. [Epub ahead of print]

PMID:
26961134
32.

Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses.

Haraldsdottir S, Hampel H, Wu C, Weng DY, Shields PG, Frankel WL, Pan X, de la Chapelle A, Goldberg RM, Bekaii-Saab T.

Genet Med. 2016 Sep;18(9):863-8. doi: 10.1038/gim.2015.184. Epub 2016 Feb 11.

33.

Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.

Song MA, Marian C, Brasky TM, Reisinger S, Djordjevic M, Shields PG.

Toxicol Lett. 2016 Mar 14;245:68-77. doi: 10.1016/j.toxlet.2016.01.012. Epub 2016 Jan 21.

34.

Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.

Song MA, Brasky TM, Marian C, Weng DY, Taslim C, Dumitrescu RG, Llanos AA, Freudenheim JL, Shields PG.

Epigenetics. 2015;10(12):1177-87. doi: 10.1080/15592294.2015.1121362.

35.

Providing a Science Base for the Evaluation of Tobacco Products.

Berman ML, Connolly G, Cummings KM, Djordjevic MV, Hatsukami DK, Henningfield JE, Myers M, O'Connor RJ, Parascandola M, Rees V, Rice JM, Shields PG.

Tob Regul Sci. 2015 Apr;1(1):76-93.

36.

Preference for Flavored Noncombustible Nicotine Products Among Smokers Motivated to Switch From Cigarettes.

Meier E, Isaksson Vogel R, O'Connor RJ, Severson HH, Shields PG, Hatsukami DK.

Nicotine Tob Res. 2016 May;18(5):892-3. doi: 10.1093/ntr/ntv259. Epub 2015 Nov 25. No abstract available.

37.

Adiposity is associated with p53 gene mutations in breast cancer.

Ochs-Balcom HM, Marian C, Nie J, Brasky TM, Goerlitz DS, Trevisan M, Edge SB, Winston J, Berry DL, Kallakury BV, Freudenheim JL, Shields PG.

Breast Cancer Res Treat. 2015 Oct;153(3):635-45. doi: 10.1007/s10549-015-3570-5. Epub 2015 Sep 12.

38.

Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers.

Weng DY, Chen J, Taslim C, Hsu PC, Marian C, David SP, Loffredo CA, Shields PG.

Mol Carcinog. 2016 Oct;55(10):1424-37. doi: 10.1002/mc.22385. Epub 2015 Aug 21.

39.

Know Your Value: Negotiation Skill Development for Junior Investigators in the Academic Environment--A Report from the American Society of Preventive Oncology's Junior Members Interest Group.

Burton-Chase AM, Swartz MC, Silvera SA, Basen-Engquist K, Fletcher FE, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1144-8. doi: 10.1158/1055-9965.EPI-15-0476. Review. No abstract available.

40.

Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue.

Roy S, Brasky TM, Belury MA, Krishnan S, Cole RM, Marian C, Yee LD, Llanos AA, Freudenheim JL, Shields PG.

Int J Cancer. 2015 Dec 15;137(12):2934-46. doi: 10.1002/ijc.29675. Epub 2015 Jul 28.

41.

Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues.

Llanos AA, Marian C, Brasky TM, Dumitrescu RG, Liu Z, Mason JB, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG.

Epigenetics. 2015;10(8):727-35. doi: 10.1080/15592294.2015.1062205. Erratum in: Epigenetics. 2015;10(11):1091.

42.

New NCCN Guidelines: Smoking Cessation for Patients With Cancer.

Shields PG.

J Natl Compr Canc Netw. 2015 May;13(5 Suppl):643-5.

PMID:
25995418
43.

Telomere length variation: A potential new telomere biomarker for lung cancer risk.

Sun B, Wang Y, Kota K, Shi Y, Motlak S, Makambi K, Loffredo CA, Shields PG, Yang Q, Harris CC, Zheng YL.

Lung Cancer. 2015 Jun;88(3):297-303. doi: 10.1016/j.lungcan.2015.03.011. Epub 2015 Mar 20.

44.

Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.

Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW.

Clin Cancer Res. 2015 Feb 1;21(3):514-25. doi: 10.1158/1078-0432.CCR-14-2544. Epub 2015 Jan 8.

45.

Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.

Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW.

J Clin Oncol. 2015 Mar 10;33(8):952-63. doi: 10.1200/JCO.2014.59.4465. Epub 2015 Jan 8.

PMID:
25572671
46.

Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.

Llanos AA, Dumitrescu RG, Brasky TM, Liu Z, Mason JB, Marian C, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG.

Carcinogenesis. 2015 Jan;36(1):60-7. doi: 10.1093/carcin/bgu219. Epub 2014 Oct 24.

47.

Genetic variation in adipokine genes and associations with adiponectin and leptin concentrations in plasma and breast tissue.

Llanos AA, Brasky TM, Mathew J, Makambi KH, Marian C, Dumitrescu RG, Freudenheim JL, Shields PG.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1559-68. doi: 10.1158/1055-9965.EPI-14-0173. Epub 2014 May 13.

48.

Mortality among capacitor workers exposed to polychlorinated biphenyls (PCBs), a long-term update.

Kimbrough RD, Krouskas CA, Xu W, Shields PG.

Int Arch Occup Environ Health. 2015 Jan;88(1):85-101. doi: 10.1007/s00420-014-0940-y. Epub 2014 Apr 22.

PMID:
24752866
49.

Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.

Mathé EA, Patterson AD, Haznadar M, Manna SK, Krausz KW, Bowman ED, Shields PG, Idle JR, Smith PB, Anami K, Kazandjian DG, Hatzakis E, Gonzalez FJ, Harris CC.

Cancer Res. 2014 Jun 15;74(12):3259-70. doi: 10.1158/0008-5472.CAN-14-0109. Epub 2014 Apr 15.

50.

Future directions for postdoctoral training in cancer prevention: insights from a panel of experts.

Nelson DE, Faupel-Badger J, Phillips S, Belcher B, Chang S, Abrams DB, Kramer BS, White MC, O'Malley M, Varanasi AP, Fabian CJ, Wiest JS, Colditz GA, Hall K, Shields PG, Weitzel JN.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):679-83. doi: 10.1158/1055-9965.EPI-13-1209. Epub 2014 Mar 6.

Supplemental Content

Loading ...
Support Center